Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Initiative aims to leverage technology in mitigating healthcare disparities

AI is a key part of the plan as two groups with little in common come together over health disparities that have only been worsened by the COVID-19 pandemic.

New international coalition pushes patient advocacy agenda

More than 100 patient groups across 38 countries have banded together to form an international patient advocacy coalition to be known as the World Patients Alliance.

Thumbnail

Liability for following AI treatment recommendations not so clear-cut, but emerging patterns suggest safe pathways

‘We find that two factors reduce lay judgment of liability: following standard care and following the recommendation of AI tools.’

Primera Blue Cross hit with $6.85M penalty, corrective action plan for HIPAA violations

The resolution represents the second largest payment to resolve a HIPAA investigation in OCR history. It also includes a robust corrective action plan that calls for, among other things, two years of monitoring.

US residents may soon be buying drugs from Canada—legally

The Trump Administration’s main aim is widening consumer access to lower prices.

Thumbnail

Washington implores parents, providers to catch kids up on regular doctor visits

So many parents have held children back from visiting clinicians’ offices during the COVID crisis that CMS is issuing an urgent call to action: Please hold them back no more.

Thumbnail

Nursing homes using hospitals as middlemen to bounce low-reimbursement, high-maintenance residents

A common tactic is sending off Medicaid-covered seniors with dementia following emergency “psychotic” episodes. When psychiatric wards and hospitals quickly discharge the patients, the nursing homes refuse to take them back in.

Thumbnail

Rand study suggests hospitals are exorbitantly overpaid by private insurers; AHA reacts

In real dollars, these payers’ combined savings would have nearly reached $20 billion just in 2018, the analysis shows.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup